Abstract
Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder characterized by its reversibility both radiologically and clinically, and it typically has a favorable prognosis. Its etiopathogenesis is not clear, although it is known that it involves endothelial dysfunction of the posterior cerebral vasculature, leading to failed cerebral autoregulation. We report a patient with PRES that may have been caused by an immune-mediated response to decitabine. Key words: Posterior reversible encephalopathy; Decitabine.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
